Pub Date : 2023-01-01Epub Date: 2023-12-30DOI: 10.34172/jcvtr.2023.33031
Arian Zargarzadeh, Elnaz Javanshir, Alireza Ghaffari, Erfan Mosharkesh, Babak Anari
Screening and early detection of cardiovascular disease (CVD) are crucial for managing progress and preventing related morbidity. In recent years, several studies have reported the important role of Artificial intelligence (AI) technology and its integration into various medical sectors. AI applications are able to deal with the massive amounts of data (medical records, ultrasounds, medications, and experimental results) generated in medicine and identify novel details that would otherwise be forgotten in the mass of healthcare data sets. Nowadays, AI algorithms are currently used to improve diagnosis of some CVDs including heart failure, atrial fibrillation, hypertrophic cardiomyopathy and pulmonary hypertension. This review summarized some AI concepts, critical execution requirements, obstacles, and new applications for CVDs.
{"title":"Artificial intelligence in cardiovascular medicine: An updated review of the literature.","authors":"Arian Zargarzadeh, Elnaz Javanshir, Alireza Ghaffari, Erfan Mosharkesh, Babak Anari","doi":"10.34172/jcvtr.2023.33031","DOIUrl":"10.34172/jcvtr.2023.33031","url":null,"abstract":"<p><p>Screening and early detection of cardiovascular disease (CVD) are crucial for managing progress and preventing related morbidity. In recent years, several studies have reported the important role of Artificial intelligence (AI) technology and its integration into various medical sectors. AI applications are able to deal with the massive amounts of data (medical records, ultrasounds, medications, and experimental results) generated in medicine and identify novel details that would otherwise be forgotten in the mass of healthcare data sets. Nowadays, AI algorithms are currently used to improve diagnosis of some CVDs including heart failure, atrial fibrillation, hypertrophic cardiomyopathy and pulmonary hypertension. This review summarized some AI concepts, critical execution requirements, obstacles, and new applications for CVDs.</p>","PeriodicalId":15207,"journal":{"name":"Journal of Cardiovascular and Thoracic Research","volume":"15 4","pages":"204-209"},"PeriodicalIF":1.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10862032/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139735339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Reply to: Analysis of covariance and sample size calculation for comparing means in randomized controlled trials.","authors":"Naimeh Mesri Alamdari, Samad Ghaffari, Neda Roshanravan","doi":"10.34172/jcvtr.2023.33034","DOIUrl":"10.34172/jcvtr.2023.33034","url":null,"abstract":"","PeriodicalId":15207,"journal":{"name":"Journal of Cardiovascular and Thoracic Research","volume":"15 4","pages":"269"},"PeriodicalIF":1.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10862033/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139735356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.34172/jcvtr.2023.31706
Rohan Magoon, Brajesh Kaushal
Dear Editor, The study by Ceylan and Yildirim outlining H2FPEF score as independent predictor of contrast-induced nephropathy (CIN) in ST-elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI), emerges as an exemplary research work.1 Nonetheless, considering the relevance of the research subject, additional insights into the topic would certainly interest the Journal readership. The authors retrospectively analyze the data of 355 patients, wherein one misses a comparative account of the serum albumin (SA) levels in the cohort developing CIN (n = 63) as opposed to those without CIN (n = 292).1 The importance of the former is heralded by the Wiedermann et al meta-analysis suggesting a causal association between hypoalbuminemia and acute kidney injury (AKI), emanating from a total of 43 studies and 68,262 subjects.2 Notably so, the meta-analysis included 8 studies with 4,344 patients combined from either cardiac surgical or PCI settings.2 More importantly, Murat et al retrospectively delineate significantly lower SA in their acute coronary syndrome (ACS) patients with contrast-induced AKI, or CI-AKI (n = 107) compared to those with normal renal function following PCI (n = 783) (3.52 ± 0.40 v/s 3.94 ± 0.39 mg/ dL, P < 0.001).3 Subsequent to a multivariate analysis, the group highlights SA as an independent CI-AKI predictor (OR; 95% CI: 0.177; 0.080-0.392, P < 0.001) in a research scenario demonstrating peculiar similarities to the Ceylan and Yildirim study.1,3 Ahead of the well-known pro-inflammatory links of both hypoalbuminemia and AKI, Wei et al elucidate a pivotal role of nutritional status in determining the eventual risk to contrast-induced renal injury in an elderly subset undergoing PCI.2-5 Indeed, the dual relationship of SA with malnutrition and inflammation cannot be overemphasized, particularly in advanced age.3,5 Moreover, whilst the inclusion of SA could have augmented the contextual research lucidity, the optimal CIN-predictive cut-off of the H2FPEF score might also require further consolidation given the recent literature in the subject (H2FPEF cut-off of 2.5 predicting CIN in ACS patients with 79.8% and 64.1% sensitivity-specificity in Ozbeyaz et al study vis-à-vis a CIN-predictive cut-off of 1.5 emanating from the Ceylan and Yildirim study and demonstrating a sensitivity-specificity of 64.0% and 72.1% in an exclusive STEMI cohort).1,6
{"title":"Contrast-induced nephropathy prediction following ST-elevation myocardial infarction: Missing links.","authors":"Rohan Magoon, Brajesh Kaushal","doi":"10.34172/jcvtr.2023.31706","DOIUrl":"https://doi.org/10.34172/jcvtr.2023.31706","url":null,"abstract":"Dear Editor, The study by Ceylan and Yildirim outlining H2FPEF score as independent predictor of contrast-induced nephropathy (CIN) in ST-elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI), emerges as an exemplary research work.1 Nonetheless, considering the relevance of the research subject, additional insights into the topic would certainly interest the Journal readership. The authors retrospectively analyze the data of 355 patients, wherein one misses a comparative account of the serum albumin (SA) levels in the cohort developing CIN (n = 63) as opposed to those without CIN (n = 292).1 The importance of the former is heralded by the Wiedermann et al meta-analysis suggesting a causal association between hypoalbuminemia and acute kidney injury (AKI), emanating from a total of 43 studies and 68,262 subjects.2 Notably so, the meta-analysis included 8 studies with 4,344 patients combined from either cardiac surgical or PCI settings.2 More importantly, Murat et al retrospectively delineate significantly lower SA in their acute coronary syndrome (ACS) patients with contrast-induced AKI, or CI-AKI (n = 107) compared to those with normal renal function following PCI (n = 783) (3.52 ± 0.40 v/s 3.94 ± 0.39 mg/ dL, P < 0.001).3 Subsequent to a multivariate analysis, the group highlights SA as an independent CI-AKI predictor (OR; 95% CI: 0.177; 0.080-0.392, P < 0.001) in a research scenario demonstrating peculiar similarities to the Ceylan and Yildirim study.1,3 Ahead of the well-known pro-inflammatory links of both hypoalbuminemia and AKI, Wei et al elucidate a pivotal role of nutritional status in determining the eventual risk to contrast-induced renal injury in an elderly subset undergoing PCI.2-5 Indeed, the dual relationship of SA with malnutrition and inflammation cannot be overemphasized, particularly in advanced age.3,5 Moreover, whilst the inclusion of SA could have augmented the contextual research lucidity, the optimal CIN-predictive cut-off of the H2FPEF score might also require further consolidation given the recent literature in the subject (H2FPEF cut-off of 2.5 predicting CIN in ACS patients with 79.8% and 64.1% sensitivity-specificity in Ozbeyaz et al study vis-à-vis a CIN-predictive cut-off of 1.5 emanating from the Ceylan and Yildirim study and demonstrating a sensitivity-specificity of 64.0% and 72.1% in an exclusive STEMI cohort).1,6","PeriodicalId":15207,"journal":{"name":"Journal of Cardiovascular and Thoracic Research","volume":"15 1","pages":"67"},"PeriodicalIF":1.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278188/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9701507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
We report a case of an 87-year-old man where coronary CT angiography incidentally demonstrated a "split" right coronary artery (RCA) featuring a "split" posterior descending artery. This case focusses on the morphological description of this variant as well as its differentiation from a "dual" or "duplicated" RCA.
{"title":"Split right coronary artery with split posterior descending artery.","authors":"Niraj Nirmal Pandey, Aprateem Mukherjee, Vineeta Ojha, Raghav Bansal, Sanjeev Kumar","doi":"10.34172/jcvtr.2023.31744","DOIUrl":"https://doi.org/10.34172/jcvtr.2023.31744","url":null,"abstract":"<p><p>We report a case of an 87-year-old man where coronary CT angiography incidentally demonstrated a \"split\" right coronary artery (RCA) featuring a \"split\" posterior descending artery. This case focusses on the morphological description of this variant as well as its differentiation from a \"dual\" or \"duplicated\" RCA.</p>","PeriodicalId":15207,"journal":{"name":"Journal of Cardiovascular and Thoracic Research","volume":"15 1","pages":"65-66"},"PeriodicalIF":1.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278192/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9707718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.34172/jcvtr.2023.31830
Neda Roshanravan, Samad Ghaffari, Sepideh Bastani, Sara Pahlavan, Samira Asghari, Mohammad Amin Doustvandi, Sepideh Jalilzadeh-Razin, Mohammadreza Dastouri
Three-dimensional (3D) myocardial tissues for studying human heart biology, physiology and pharmacology have recently received lots of attention. Organoids as 3D mini-organs are created from multiple cell types (i.e. induced pluripotent stem cells (iPSCs) or embryonic stem cells (ESCs)) with other supporting co-cultured cells such as endothelial cells or fibroblasts. Cardiac organoid culture technologies are bringing about significant advances in organ research and allows for the establishment of tissue regeneration and disease modeling. The present review provides an overview of the recent advances in human cardiac organoid platforms in disease biology and for cardiovascular regenerative medicine.
{"title":"Human cardiac organoids: A recent revolution in disease modeling and regenerative medicine.","authors":"Neda Roshanravan, Samad Ghaffari, Sepideh Bastani, Sara Pahlavan, Samira Asghari, Mohammad Amin Doustvandi, Sepideh Jalilzadeh-Razin, Mohammadreza Dastouri","doi":"10.34172/jcvtr.2023.31830","DOIUrl":"https://doi.org/10.34172/jcvtr.2023.31830","url":null,"abstract":"<p><p>Three-dimensional (3D) myocardial tissues for studying human heart biology, physiology and pharmacology have recently received lots of attention. Organoids as 3D mini-organs are created from multiple cell types (i.e. induced pluripotent stem cells (iPSCs) or embryonic stem cells (ESCs)) with other supporting co-cultured cells such as endothelial cells or fibroblasts. Cardiac organoid culture technologies are bringing about significant advances in organ research and allows for the establishment of tissue regeneration and disease modeling. The present review provides an overview of the recent advances in human cardiac organoid platforms in disease biology and for cardiovascular regenerative medicine.</p>","PeriodicalId":15207,"journal":{"name":"Journal of Cardiovascular and Thoracic Research","volume":"15 2","pages":"68-72"},"PeriodicalIF":1.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466470/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10491411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ventricular dysfunction is the most frequent complication in adult patients post-Fontan completion. Through this work, we aim to evaluate ventricular systolic function by conventional echographic parameters and by global longitudinal strain (GLS) to determine the prediction of early ventricular systolic dysfunction. This is a prospective monocentric study enrolling 15 clinically stable adult Fontan patients with preserved ejection fraction (EF). Myocardial deformation study by GLS with speckle tracking technique in addition to a standard Doppler transthoracic echocardiography (TTE) was performed. Cardiac magnetic resonance imaging (CMR) was also performed. A comparison of echocardiographic and CMR parameters was made. In comparison to CMR-derived EF, we found a significant correlation with GLS and TTE-derived EF (P=0.003 and 0.014). We divided our population into two groups based on the cut-off value of 50% of CMR derived EF. Comparison of GLS in both groups showed a significant correlation (P=0.003). A cut-off value of -13.3% showed sensitivity of 67% and specificity of 100%. GLS has a moderate diagnostic value for systolic myocardial dysfunction in the population of adult patients with Fontan circulation.
心室功能障碍是方坦手术后成年患者最常见的并发症。通过这项工作,我们旨在用常规超声参数和整体纵向应变(GLS)评估心室收缩功能,以确定早期心室收缩功能障碍的预测。这是一项前瞻性单中心研究,共招募了15名临床稳定、射血分数(EF)保留的成年丰坦患者。除了标准的多普勒经胸超声心动图(TTE)外,还采用斑点追踪技术进行了GLS心肌变形研究。此外,还进行了心脏磁共振成像(CMR)。对超声心动图和 CMR 参数进行了比较。与 CMR 导出的 EF 相比,我们发现 GLS 和 TTE 导出的 EF 存在显著相关性(P=0.003 和 0.014)。我们根据 CMR 导出 EF 的 50% 临界值将人群分为两组。两组中 GLS 的比较显示出显著的相关性(P=0.003)。-13.3%的临界值显示敏感性为67%,特异性为100%。在丰坦循环成年患者中,GLS对收缩性心肌功能障碍具有中等诊断价值。
{"title":"Assessment of ventricular function after total cavo-pulmonary derivation in adult patients: Interest of global longitudinal strain.","authors":"Kaouther Hakim, Nouha Mekki, Rihab Benothmen, Mokbli Malek, Jarray Abdelkader, Msaad Hela, Habiba Mizouni, Ouarda Fatma","doi":"10.34172/jcvtr.2023.32880","DOIUrl":"10.34172/jcvtr.2023.32880","url":null,"abstract":"<p><p>Ventricular dysfunction is the most frequent complication in adult patients post-Fontan completion. Through this work, we aim to evaluate ventricular systolic function by conventional echographic parameters and by global longitudinal strain (GLS) to determine the prediction of early ventricular systolic dysfunction. This is a prospective monocentric study enrolling 15 clinically stable adult Fontan patients with preserved ejection fraction (EF). Myocardial deformation study by GLS with speckle tracking technique in addition to a standard Doppler transthoracic echocardiography (TTE) was performed. Cardiac magnetic resonance imaging (CMR) was also performed. A comparison of echocardiographic and CMR parameters was made. In comparison to CMR-derived EF, we found a significant correlation with GLS and TTE-derived EF (<i>P</i>=0.003 and 0.014). We divided our population into two groups based on the cut-off value of 50% of CMR derived EF. Comparison of GLS in both groups showed a significant correlation (<i>P</i>=0.003). A cut-off value of -13.3% showed sensitivity of 67% and specificity of 100%. GLS has a moderate diagnostic value for systolic myocardial dysfunction in the population of adult patients with Fontan circulation.</p>","PeriodicalId":15207,"journal":{"name":"Journal of Cardiovascular and Thoracic Research","volume":"15 4","pages":"262-268"},"PeriodicalIF":1.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10862030/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139735340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Natural decellularized patches have been developed as the therapeutic platform for the treatment of different diseases, especially cardiovascular disorders. Decellularized scaffolds (as both cell-seeded and cell-free patches) are broadly studied in heart tissue redevelopment in vivo and in vitro. The designed regenerative bio-scaffold must have desirable physicochemical properties including mechanical stiffness for load-bearing, and appropriate anatomical characteristics to mimic the native biological environment properly and facilitate tissue reconstruction. In this context, the current study was designed to investigate rabbit decellularized derma's similarity with human decellularized skin in terms of mechanical properties for cardiac tissue engineering application.
Methods: Fifty two rabbit dermal specimens were provided and divided into two groups: the experimental (decellularized) group and the control (group). Similarly, twelve human skin specimens were divided into the experimental (decellularized) and control groups. Initially, the effect of decellularization on the mechanical performance of scaffolds was analyzed. Then, the mechanical strength of decellularized rabbit skin was compared to decellularized human derma by measuring the stress strain and Young's modulus of the samples.
Results: The results showed that rabbit decellularized skin has a similar elastic range to human decellularized skin, despite being more elastic (P>0.05). In addition, after decellularization, both rabbit and human skin showed a non-significant decrease in elasticity (P>0.05). It is worth noting that the elasticity reduction in rabbit samples after skin decellularization was lower than in human samples.
Conclusion: According to the results of this study and the similarities of rabbit decellularized derm to human skin and its advantages over it, along with the biological complexity of native cardiac ECM, this scaffold can be used as an alternative matrix for tissue-engineered cardiac patches.
{"title":"Mechanical properties of the rabbit and human decellularized patches for well-tolerated/reinforced organ in cardiac tissue engineering.","authors":"Maryam Mousavi Khatat, Saeideh Same, Keyvan Moharamzadeh, Jafar Soleimani Rad, Ahmad Mehdipour, Leila Roshangar","doi":"10.34172/jcvtr.2023.32926","DOIUrl":"10.34172/jcvtr.2023.32926","url":null,"abstract":"<p><strong>Introduction: </strong>Natural decellularized patches have been developed as the therapeutic platform for the treatment of different diseases, especially cardiovascular disorders. Decellularized scaffolds (as both cell-seeded and cell-free patches) are broadly studied in heart tissue redevelopment in vivo and in vitro. The designed regenerative bio-scaffold must have desirable physicochemical properties including mechanical stiffness for load-bearing, and appropriate anatomical characteristics to mimic the native biological environment properly and facilitate tissue reconstruction. In this context, the current study was designed to investigate rabbit decellularized derma's similarity with human decellularized skin in terms of mechanical properties for cardiac tissue engineering application.</p><p><strong>Methods: </strong>Fifty two rabbit dermal specimens were provided and divided into two groups: the experimental (decellularized) group and the control (group). Similarly, twelve human skin specimens were divided into the experimental (decellularized) and control groups. Initially, the effect of decellularization on the mechanical performance of scaffolds was analyzed. Then, the mechanical strength of decellularized rabbit skin was compared to decellularized human derma by measuring the stress strain and Young's modulus of the samples.</p><p><strong>Results: </strong>The results showed that rabbit decellularized skin has a similar elastic range to human decellularized skin, despite being more elastic (<i>P</i>>0.05). In addition, after decellularization, both rabbit and human skin showed a non-significant decrease in elasticity (<i>P</i>>0.05). It is worth noting that the elasticity reduction in rabbit samples after skin decellularization was lower than in human samples.</p><p><strong>Conclusion: </strong>According to the results of this study and the similarities of rabbit decellularized derm to human skin and its advantages over it, along with the biological complexity of native cardiac ECM, this scaffold can be used as an alternative matrix for tissue-engineered cardiac patches.</p>","PeriodicalId":15207,"journal":{"name":"Journal of Cardiovascular and Thoracic Research","volume":"15 4","pages":"244-249"},"PeriodicalIF":1.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10862031/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139735353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01Epub Date: 2023-12-30DOI: 10.34172/jcvtr.2023.31693
Ali Farshbaf Khalili, Shahryar Razzaghi, Zeinab Nikniaz, Leila Nikniaz, Ali Hossein Zeinalzadeh
Introduction: Metabolic syndrome (MetS) is a prevalent metabolic disorder with increasing prevalence attributed to extended life expectancy. This study aims to investigate MetS prevalence and its determinants in the East-Azerbaijan population.
Methods: Conducted as a cross-sectional study within the East Azerbaijan region, this research is based on a major Lifestyle Promotion Project. The study encompasses 700 participants aged 15 to 65 years, representing the general population and selected using probability proportional to size multistage stratified cluster sampling. MetS diagnoses were conducted using the adult Panel III criteria. Data on socio-demographics, smoking status, and physical activity levels were collected through questionnaires.
Results: Among participants, the mean age was 42.4±12.38 years, and the mean body mass index was 27.69±4.94 kg/m2. The MetS group exhibited higher mean age and body mass index compared to the non-MetS group (P<0.001). The prevalence of MetS in the population was 34.2%, with higher rates in females (37.1%) compared to males (30.5%), though this difference wasn't statistically significant (P=0.11). Notably, a substantial distinction was observed between the two groups regarding education levels (P<0.001).
Conclusion: The study reveals a significant association between increasing age and higher prevalence of MetS. Furthermore, lower educational levels were linked to an elevated prevalence of MetS. While other socio-demographic factors didn't demonstrate statistically significant relationships, these findings emphasize the importance of targeted interventions and education in mitigating MetS risks.
{"title":"Prevalence of metabolic syndrome in East Azerbaijan-Iran and its determinants factors.","authors":"Ali Farshbaf Khalili, Shahryar Razzaghi, Zeinab Nikniaz, Leila Nikniaz, Ali Hossein Zeinalzadeh","doi":"10.34172/jcvtr.2023.31693","DOIUrl":"10.34172/jcvtr.2023.31693","url":null,"abstract":"<p><strong>Introduction: </strong>Metabolic syndrome (MetS) is a prevalent metabolic disorder with increasing prevalence attributed to extended life expectancy. This study aims to investigate MetS prevalence and its determinants in the East-Azerbaijan population.</p><p><strong>Methods: </strong>Conducted as a cross-sectional study within the East Azerbaijan region, this research is based on a major Lifestyle Promotion Project. The study encompasses 700 participants aged 15 to 65 years, representing the general population and selected using probability proportional to size multistage stratified cluster sampling. MetS diagnoses were conducted using the adult Panel III criteria. Data on socio-demographics, smoking status, and physical activity levels were collected through questionnaires.</p><p><strong>Results: </strong>Among participants, the mean age was 42.4±12.38 years, and the mean body mass index was 27.69±4.94 kg/m2. The MetS group exhibited higher mean age and body mass index compared to the non-MetS group (<i>P</i><0.001). The prevalence of MetS in the population was 34.2%, with higher rates in females (37.1%) compared to males (30.5%), though this difference wasn't statistically significant (<i>P</i>=0.11). Notably, a substantial distinction was observed between the two groups regarding education levels (<i>P</i><0.001).</p><p><strong>Conclusion: </strong>The study reveals a significant association between increasing age and higher prevalence of MetS. Furthermore, lower educational levels were linked to an elevated prevalence of MetS. While other socio-demographic factors didn't demonstrate statistically significant relationships, these findings emphasize the importance of targeted interventions and education in mitigating MetS risks.</p>","PeriodicalId":15207,"journal":{"name":"Journal of Cardiovascular and Thoracic Research","volume":"15 4","pages":"238-243"},"PeriodicalIF":1.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10862039/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139735355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.34172/jcvtr.2023.31585
Mehrzad Mirshekari, Nooshin Shirzad, Mahboobeh Hemmatabadi, Soha Namazi
Introduction: Optimal treatment of dyslipidemia is a top priority in the prevention of cardiovascular diseases. For this purpose, clinicians in Iran usually refer to four current international guidelines. The aim of this study was to assess the approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines. Methods: A structured questionnaire was prepared. Questions (n=24) included the demographics (n=7), dyslipidemia references (n=3), dyslipidemia general knowledge of respondents (n=10), and questions (n=4) designed based on the difference among the latest version of guidelines participants stated they use in their practice. After validity conformation, the questionnaire was distributed to 120 clinical pharmacists, electronically from May to August 2021. Results: Response rate was 77.5% (n=93). The majority of participants (80.6%, n=75) claimed to have used the 2018 ACC/AHA guideline. The Median (interquartile range [IQR]) score of the general knowledge questions was 5.0 (2.0) out of 10. The Median (IQR) score of questions designed based on the difference among guidelines was calculated 3(1) out of 4. There was no significant (P=0.25) difference in score among participants according to their guideline selection. Moreover, the gender and length of experience as a clinical pharmacist had no significant (P>0.05) effect on the score of participants. Conclusion: In this study, Iranian clinical pharmacists answered half of the dyslipidemia general knowledge questions correctly. Also, Participants were up-to-date on 75% of the questions designed based on the latest version of the guideline they had been using in their practice.
{"title":"The approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines.","authors":"Mehrzad Mirshekari, Nooshin Shirzad, Mahboobeh Hemmatabadi, Soha Namazi","doi":"10.34172/jcvtr.2023.31585","DOIUrl":"https://doi.org/10.34172/jcvtr.2023.31585","url":null,"abstract":"<p><p><b><i>Introduction:</i></b> Optimal treatment of dyslipidemia is a top priority in the prevention of cardiovascular diseases. For this purpose, clinicians in Iran usually refer to four current international guidelines. The aim of this study was to assess the approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines. <b><i>Methods:</i></b> A structured questionnaire was prepared. Questions (n=24) included the demographics (n=7), dyslipidemia references (n=3), dyslipidemia general knowledge of respondents (n=10), and questions (n=4) designed based on the difference among the latest version of guidelines participants stated they use in their practice. After validity conformation, the questionnaire was distributed to 120 clinical pharmacists, electronically from May to August 2021. <b><i>Results:</i></b> Response rate was 77.5% (n=93). The majority of participants (80.6%, n=75) claimed to have used the 2018 ACC/AHA guideline. The Median (interquartile range [IQR]) score of the general knowledge questions was 5.0 (2.0) out of 10. The Median (IQR) score of questions designed based on the difference among guidelines was calculated 3(1) out of 4. There was no significant (<i>P</i>=0.25) difference in score among participants according to their guideline selection. Moreover, the gender and length of experience as a clinical pharmacist had no significant (<i>P</i>>0.05) effect on the score of participants. <b><i>Conclusion:</i></b> In this study, Iranian clinical pharmacists answered half of the dyslipidemia general knowledge questions correctly. Also, Participants were up-to-date on 75% of the questions designed based on the latest version of the guideline they had been using in their practice.</p>","PeriodicalId":15207,"journal":{"name":"Journal of Cardiovascular and Thoracic Research","volume":"15 1","pages":"30-36"},"PeriodicalIF":1.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278195/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9701510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.34172/jcvtr.2023.31618
Khadije Mohammadi, Parya Soltani, Nazanin Davari
COVID-19 has been known to induce systemic inflammation and hyper coagulate state leading to different complications. Cardiovascular complications are one of the most important among complications following COVID-19 infection. A 57 years old woman with past medical history of COVID-19 infection about two months ago came to our hospital with presentation of fever and dyspnea. During workup, tricuspid valve infection associated with pulmonary septic emboli was diagnosed without any obvious risk factor for infective endocarditis. It seems that COVID-19 infection may increase the rate of endocarditis in patients with or without risk factors of endocarditis.
{"title":"Infective Endocarditis as a complication of COVID-19 infection; A case report and review of literature.","authors":"Khadije Mohammadi, Parya Soltani, Nazanin Davari","doi":"10.34172/jcvtr.2023.31618","DOIUrl":"https://doi.org/10.34172/jcvtr.2023.31618","url":null,"abstract":"<p><p>COVID-19 has been known to induce systemic inflammation and hyper coagulate state leading to different complications. Cardiovascular complications are one of the most important among complications following COVID-19 infection. A 57 years old woman with past medical history of COVID-19 infection about two months ago came to our hospital with presentation of fever and dyspnea. During workup, tricuspid valve infection associated with pulmonary septic emboli was diagnosed without any obvious risk factor for infective endocarditis. It seems that COVID-19 infection may increase the rate of endocarditis in patients with or without risk factors of endocarditis.</p>","PeriodicalId":15207,"journal":{"name":"Journal of Cardiovascular and Thoracic Research","volume":"15 2","pages":"127-130"},"PeriodicalIF":1.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466469/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10491413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}